Boehringer Ingelheim receives EMA marketing authorization for NexGard COMBO, the first isoxazoline-based full endectocide for cats
This innovative broad spectrum topical parasiticide is easy and convenient for cat owners.
It kills a wider range of parasites than any other product on the market, covering core external parasites like fleas and ticks as well as internal parasites, including tapeworms.
Boehringer Ingelheim, a global leader in animal health, is proud to announce that it has received marketing authorization from the EMA (European Medicine Agency) and European Commission for its NexGard COMBO topical solution for cats. This innovative parasiticide will be available in the European Union shortly. NexGard